vs
Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $64.3M, roughly 1.3× CAMDEN NATIONAL CORP). CAMDEN NATIONAL CORP runs the higher net margin — 34.0% vs 22.8%, a 11.2% gap on every dollar of revenue. Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 22.6%).
Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
CAC vs FDMT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $64.3M | $85.1M |
| Net Profit | $21.9M | $19.4M |
| Gross Margin | — | — |
| Operating Margin | — | 17.3% |
| Net Margin | 34.0% | 22.8% |
| Revenue YoY | — | 8508900.0% |
| Net Profit YoY | — | 139.1% |
| EPS (diluted) | $1.29 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $64.3M | — | ||
| Q4 25 | $68.1M | $85.1M | ||
| Q3 25 | $65.4M | $90.0K | ||
| Q2 25 | $62.3M | $15.0K | ||
| Q1 25 | $60.1M | $14.0K | ||
| Q4 24 | $47.6M | $1.0K | ||
| Q3 24 | $45.0M | $3.0K | ||
| Q2 24 | $42.8M | $5.0K |
| Q1 26 | $21.9M | — | ||
| Q4 25 | $22.6M | $19.4M | ||
| Q3 25 | $21.2M | $-56.9M | ||
| Q2 25 | $14.1M | $-54.7M | ||
| Q1 25 | $7.3M | $-48.0M | ||
| Q4 24 | $14.7M | — | ||
| Q3 24 | $13.1M | $-43.8M | ||
| Q2 24 | $12.0M | $-35.0M |
| Q1 26 | — | — | ||
| Q4 25 | 41.5% | 17.3% | ||
| Q3 25 | 40.5% | -67983.3% | ||
| Q2 25 | 28.5% | -396373.3% | ||
| Q1 25 | 10.3% | -383007.1% | ||
| Q4 24 | 38.7% | — | ||
| Q3 24 | 35.2% | -1704400.0% | ||
| Q2 24 | 34.7% | -849120.0% |
| Q1 26 | 34.0% | — | ||
| Q4 25 | 33.1% | 22.8% | ||
| Q3 25 | 32.4% | -63195.6% | ||
| Q2 25 | 22.6% | -364386.7% | ||
| Q1 25 | 12.2% | -342657.1% | ||
| Q4 24 | 30.8% | — | ||
| Q3 24 | 29.1% | -1461433.3% | ||
| Q2 24 | 28.0% | -699060.0% |
| Q1 26 | $1.29 | — | ||
| Q4 25 | $1.33 | $0.43 | ||
| Q3 25 | $1.25 | $-1.01 | ||
| Q2 25 | $0.83 | $-0.98 | ||
| Q1 25 | $0.43 | $-0.86 | ||
| Q4 24 | $1.00 | — | ||
| Q3 24 | $0.90 | $-0.79 | ||
| Q2 24 | $0.81 | $-0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $402.7M |
| Total DebtLower is stronger | $514.4M | — |
| Stockholders' EquityBook value | $710.0M | $505.7M |
| Total Assets | $7.0B | $566.7M |
| Debt / EquityLower = less leverage | 0.72× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $402.7M | ||
| Q3 25 | — | $305.1M | ||
| Q2 25 | — | $293.2M | ||
| Q1 25 | — | $321.4M | ||
| Q4 24 | — | $424.9M | ||
| Q3 24 | — | $501.9M | ||
| Q2 24 | — | $541.9M |
| Q1 26 | $514.4M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $710.0M | — | ||
| Q4 25 | $696.6M | $505.7M | ||
| Q3 25 | $676.4M | $369.0M | ||
| Q2 25 | $652.1M | $420.9M | ||
| Q1 25 | $640.1M | $469.7M | ||
| Q4 24 | $531.2M | $510.6M | ||
| Q3 24 | $529.9M | $552.9M | ||
| Q2 24 | $508.3M | $588.3M |
| Q1 26 | $7.0B | — | ||
| Q4 25 | $7.0B | $566.7M | ||
| Q3 25 | $7.0B | $424.0M | ||
| Q2 25 | $6.9B | $473.6M | ||
| Q1 25 | $7.0B | $515.7M | ||
| Q4 24 | $5.8B | $560.4M | ||
| Q3 24 | $5.7B | $604.0M | ||
| Q2 24 | $5.7B | $620.1M |
| Q1 26 | 0.72× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $28.6M |
| Free Cash FlowOCF − Capex | — | $28.5M |
| FCF MarginFCF / Revenue | — | 33.5% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.9M | $28.6M | ||
| Q3 25 | $36.1M | $-46.5M | ||
| Q2 25 | $6.0M | $-43.4M | ||
| Q1 25 | $1.0M | $-47.8M | ||
| Q4 24 | $60.9M | $-134.6M | ||
| Q3 24 | $-14.5M | $-29.4M | ||
| Q2 24 | $14.5M | $-30.2M |
| Q1 26 | — | — | ||
| Q4 25 | $58.2M | $28.5M | ||
| Q3 25 | $35.4M | $-46.6M | ||
| Q2 25 | $4.5M | $-43.4M | ||
| Q1 25 | $-727.0K | $-48.4M | ||
| Q4 24 | $55.4M | $-138.4M | ||
| Q3 24 | $-16.2M | $-31.2M | ||
| Q2 24 | $13.2M | $-30.6M |
| Q1 26 | — | — | ||
| Q4 25 | 85.5% | 33.5% | ||
| Q3 25 | 54.1% | -51765.6% | ||
| Q2 25 | 7.3% | -289620.0% | ||
| Q1 25 | -1.2% | -345635.7% | ||
| Q4 24 | 116.4% | -13837100.0% | ||
| Q3 24 | -36.0% | -1038966.7% | ||
| Q2 24 | 30.8% | -611840.0% |
| Q1 26 | — | — | ||
| Q4 25 | 8.4% | 0.1% | ||
| Q3 25 | 1.1% | 101.1% | ||
| Q2 25 | 2.4% | 440.0% | ||
| Q1 25 | 2.9% | 4507.1% | ||
| Q4 24 | 11.7% | 378600.0% | ||
| Q3 24 | 3.8% | 59266.7% | ||
| Q2 24 | 3.0% | 6980.0% |
| Q1 26 | — | — | ||
| Q4 25 | 2.83× | 1.47× | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | 4.15× | — | ||
| Q3 24 | -1.11× | — | ||
| Q2 24 | 1.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAC
| Net Interest Income | $52.4M | 81% |
| Noninterest Income | $12.0M | 19% |
FDMT
Segment breakdown not available.
